J3315 HCPCS Level II code: Injection, triptorelin pamoate, 3.75 mg
J3315 is the HCPCS code for “Injection, triptorelin pamoate, 3.75 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3315Injection, triptorelin pamoate, 3.75 mg
Short description: Triptorelin pamoate
HCPCS · United States
Medicare details
The indicators CMS publishes with J3315 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2003
Where J3315 sits
- 1J codesDrugs administered other than orally
- 2Active code J3315Injection, triptorelin pamoate, 3.75 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3315 mean?
J3315 is the HCPCS code for “Injection, triptorelin pamoate, 3.75 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3315?
CMS lists J3315’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3315
All J codesJ3301Injection, triamcinolone acetonide, not otherwise specified, 10 mgJ3302Injection, triamcinolone diacetate, per 5 mgJ3303Injection, triamcinolone hexacetonide, per 5 mgJ3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgJ3305Injection, trimetrexate glucuronate, per 25 mgJ3310Injection, perphenazine, up to 5 mgJ3316Injection, triptorelin, extended-release, 3.75 mgJ3320Injection, spectinomycin dihydrochloride, up to 2 gmJ3350Injection, urea, up to 40 gmJ3355Injection, urofollitropin, 75 iuJ3357Ustekinumab, for subcutaneous injection, 1 mgJ3358Ustekinumab, for intravenous injection, 1 mg